https://www.selleckchem.com/pr....oducts/ono-ae3-208.h
Thirty-two percent of patients reported concerns about tumour recurrence elsewhere in the body. The brachytherapy group had a significantly higher "role functioning" score (p = 0.03. Enucleation patients were more likely to have problems with appearance (p less then 0.0005). Younger patients (12-54 years of age) were more likely to report headaches (p less then 0.0005) and problems with reading (p = 0.042), and they had a lower cognitive functioning score (p = 0.003) than those aged ≥55 years. Conclusions There was no significant
إعجاب
علق
شارك
